動物用ワクチン市場-2027年までの予測

Animal Vaccines MarketForecast to 2027

動物用ワクチン市場-2027年までの予測市場予測動物用ワクチン市場は、予測期間中に7.50%の大幅なCAGRを目撃し、2020年には最高の市場価値である80億1306万米ドルに達すると予測されます。動物用ワクチン市... もっと見る

出版社	出版年月	価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2022年5月3日	お問い合わせくださいライセンス・価格情報・注文方法はこちら	169	英語

サマリー

動物用ワクチン市場-2027年までの予測

市場予測
動物用ワクチン市場は、予測期間中に7.50%の大幅なCAGRを目撃し、2020年には最高の市場価値である80億1306万米ドルに達すると予測されます。動物用ワクチン市場調査は、市場規模の調査、生産者のアイテムや管理方法の徹底的な検証を組み込んでいます。世界の動物用ワクチン市場の発展は、動物における人獣共通感染症や進行中の感染症の増加、動物医療サービスや予防接種のアクセントの拡大に起因するものです。しかし、ワクチンに関する高額の費用や厳格な管理規則が、動物用ワクチン市場の制限要因となっています。また、異なる動物種にワクチンを接種するために送り出されるアイテムの数が増加していることも、動物用ワクチン市場の発展につながっています。
世界保健機関（WHO）の洞察によると、約59,000人の人間の死亡は、世界中で狂犬病感染によって毎年起こります。このような病気の蔓延が、動物用ワクチンへの関心の高まりに拍車をかけています。さらに、進行中の病気の数の開発の背後にある主要な目的の一つは、作成された医療ケアオフィスと偉大な栄養のために、ペットの将来の上昇です。さらに、動物の健康の将来は、動物の幸福と比類のない患者の配慮、新しいアイテムの進歩、およびワクチンの協力的な改善における革新的な進歩に依存しています。ペットを飼っている人たちは、自分のパートナーのために、入手しやすい最高の薬を探すために、より高い金額を費やすようになっています。そのため、動物病院への関心も高まっています。また、世界中の議会が動物病院に対して巨額の支出を行っています。
市場区分

動物用ワクチンの世界市場のセグメント分析は、タイプ、技術、地域の観点から実施されます。
タイプ別では、世界市場は家禽用ワクチン、家畜用ワクチン、コンパニオンアニマル用ワクチン、豚用ワクチン、水産養殖用ワクチンに分類されます。技術分野では、世界市場を毒素ワクチン、組み換えワクチン、弱毒生ワクチン、不活性化ワクチン、その他に分けます。

地域別分析

地域的には、世界の動物用ワクチン市場は、南北アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカの4つの主要地域に広がっています。
アメリカ大陸は、2020年に最大の市場シェアを獲得し、世界の動物ワクチン市場をリードすると思われます。動物疾病の発生率の増加やペットの飼育数の増加が、今後この地域の市場を押し上げると予想されます。また、口蹄疫や犬パルボウイルス、生殖・呼吸器症候群の症例が増加していることも、アメリカ大陸のさらなる市場成長を後押ししています。

ヨーロッパ地域は、アジア太平洋地域に続いて、動物用ワクチンの注目すべき市場を獲得すると予想されています。この地域の市場は、ペット人口の増加や研究開発費の増加に起因しています。アジア太平洋地域の動物用ワクチン市場は、動物の健康に対する意識の高まり、家畜の飼育頭数の増加、動物の病気の症例数の増加などに起因しています。

主要企業
世界の動物用ワクチン市場調査報告書に含まれる主要企業は、セバ・サンテ・アニマル（フランス）、ビルバック（フランス）、フィブロ・アニマルヘルス・コーポレーション（米国）、ヒプラ（スペイン）、ベーリンガーインゲルハイム国際GmbH（ドイツ）、ゾエティス（米国）、バイオジェネシスバゴS.A.（アルゼンチン）、メルク＆カンパニー（米国）、エランコ・アニマルヘルス・インコーポレイテッド（米国）およびネオジェン・カンパニー（米国）です。

COVID 19の影響
当社は、COVID-19のパンデミックがあらゆる領域の様々な業界や業種に与える影響を継続的に追跡しています。当社の調査レポートには、COVID-19が各産業に与える影響による低下と上昇を理解するのに役立つ情報が含まれています。また、我々はあなたが興味を持っている市場の需要と供給の間のギャップを識別するのに役立ちます。さらに、このレポートは、分析、改正された政府の規制、および他の多くの有用な洞察であなたを助けます。

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING ZOONOTIC AND CHRONIC DISEASES IN ANIMALS

4.2.2 INCREASING EMPHASIS ON ANIMAL HEALTHCARE AND VACCINATION

4.2.3 INCREASED CONSUMPTION OF ANIMAL-BASED PRODUCTS

4.3 RESTRAINT

4.3.1 STRINGENT REGULATORY GUIDELINESANDHIGH STORAGE COSTSASSOCIATED WITH ANIMAL VACCINES

4.4 OPPORTUNITY

4.4.1 RISING INVESTMENTS IN VETERINARY HOSPITALSTO IMPROVE ANIMAL HEALTH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 RESEARCH & DEVELOPMENT

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19ON THE GLOBAL ANIMAL VACCINES MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT OF COVID-19 ON ANIMAL DISEASE PREVENTION & CONTROL

5.3.3 IMPACT ON MARKET

6 GLOBAL ANIMAL VACCINES MARKET, BY TYPE

6.1 OVERVIEW

6.2 PORCINE VACCINES

6.3 POULTRY VACCINES

6.4 LIVESTOCK VACCINES

6.4.1 BOVINE VACCINES

6.4.2 SMALL RUMINANT VACCINES

6.5 COMPANION ANIMAL VACCINES

6.5.1 CANINE VACCINES

6.5.2 FELINE VACCINES

6.5.3 OTHERS

6.6 AQUACULTUTRE VACCINES

7 GLOBAL ANIMAL VACCINES MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 LIVE ATTENUATED VACCINES

7.3 INACTIVATED VACCINES

7.4 TOXOID VACCINES

7.5 RECOMBINANT VACCINES

7.6 OTHERS

8 GLOBAL ANIMAL VACCINES MARKET, BY REGION

8.1 OVERVIEW

8.2 AMERICAS

8.2.1 NORTH AMERICA

8.2.1.1 US

8.2.1.2 CANADA

8.2.2 SOUTH AMERICA

8.3 EUROPE

8.3.1 WESTERN EUROPE

8.3.1.1 FRANCE

8.3.1.2 GERMANY

8.3.1.3 UK

8.3.1.4 SPAIN

8.3.1.5 ITALY

8.3.1.6 REST OF WESTERN EUROPE

8.3.2 EASTERN EUROPE

8.4 ASIA-PACIFIC

8.4.1 JAPAN

8.4.2 CHINA

8.4.3 INDIA

8.4.4 AUSTRALIA

8.4.5 REPUBLIC OF KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST

8.5.2 AFRICA

9 COMPETITIVE LANDSCAPE

9.1 COMPETITIVEOVERVIEW

9.2 MAJOR PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

9.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ANIMAL VACCINES MARKET

9.4 COMPETITIVE BENCHMARKING

9.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ANIMAL VACCINES MARKET

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

9.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

9.7 MAJOR PLAYERS FINANCIAL MATRIX

9.7.1 REVENUE OF MAJOR PLAYERS, 2020

9.7.2 R&D EXPENDITURE, 2020

10 COMPANY PROFILES

10.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 ZOETIS INC.

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS.

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 CEVA SANTÉ ANIMALE

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS/SERVICES OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 KEY STRATEGIES

10.4 MERCK & CO., INC.

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 KEY STRATEGIES

10.5 ELANCO ANIMAL HEALTH INCORPORATED

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6 VIRBAC

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 KEY STRATEGIES

10.7 PHIBRO ANIMAL HEALTH CORPORATION

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 KEY STRATEGIES

10.8 HIPRA

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 KEY STRATEGIES

10.9 BIOGÉNESIS BAGÓ S.A.

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 KEY STRATEGIES

10.10 NEOGEN CORPORATION

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: ANIMAL VACCINE MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: ANIMAL VACCINE MARKET, FOR PORCINE VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: ANIMAL VACCINE MARKET, FOR POULTRY VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: ANIMAL VACCINE MARKET, FOR LIVESTOCK VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: ANIMAL VACCINE MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: ANIMAL VACCINE MARKET, FOR BOVINE VACCINES, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: ANIMAL VACCINE MARKET, FOR SMALL RUMINANT VACCINES, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: ANIMAL VACCINE MARKET, FOR COMPANION ANIMAL VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: ANIMAL VACCINE MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: ANIMAL VACCINE MARKET, FOR CANINE VACCINES, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: ANIMAL VACCINE MARKET, FOR FELINE VACCINES, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: ANIMAL VACCINE MARKET, FOR OTHERS, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: ANIMAL VACCINE MARKET, FOR AQUACULTUTRE VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: ANIMAL VACCINE MARKET, FOR LIVE ATTENUATED VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: ANIMAL VACCINE MARKET, FOR INACTIVATED VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: ANIMAL VACCINE MARKET, FOR TOXOID VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: ANIMAL VACCINE MARKET, FOR RECOMBINANT VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: ANIMAL VACCINE MARKET, FOR OTHER VACCINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 AMERICAS: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 AMERICAS: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 25 AMERICAS: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 26 AMERICAS: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 27 AMERICAS: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 28 NORTH AMERICA: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 29 NORTH AMERICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 30 NORTH AMERICA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 31 NORTH AMERICA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 32 NORTH AMERICA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 33 US: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 34 US: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 35 US: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 36 US: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 37 CANADA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 38 CANADA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 39 CANADA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 40 CANADA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 41 SOUTH AMERICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 42 SOUTH AMERICA: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 43 SOUTH AMERICA: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 44 SOUTH AMERICA: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 45 EUROPE: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 46 EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 47 EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 48 EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 49 EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 50 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 51 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 52 WESTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 53 WESTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 54 WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 55 FRANCE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 56 FRANCE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 57 FRANCE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 58 FRANCE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 59 GERMANY: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 60 GERMANY: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 61 GERMANY: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 62 GERMANY: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 63 UK: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 64 UK: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 65 UK: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 66 UK: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 67 SPAIN: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 68 SPAIN: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 69 SPAIN: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 70 SPAIN: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 71 ITALY: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 72 ITALY: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 73 ITALY: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 74 ITALY: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 75 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 76 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 77 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 78 REST OF WESTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 79 EASTERN EUROPE: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 80 EASTERN EUROPE: ANIMAL VACCINES MARKET , BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 81 EASTERN EUROPE: ANIMAL VACCINES MARKET , BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 82 EASTERN EUROPE: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 83 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 84 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 88 JAPAN: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 89 JAPAN: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 90 JAPAN: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 91 JAPAN: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 92 CHINA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 93 CHINA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 94 CHINA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 95 CHINA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 96 INDIA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 97 INDIA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 98 INDIA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 99 INDIA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 100 AUSTRALIA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 101 AUSTRALIA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 102 AUSTRALIA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 103 AUSTRALIA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 104 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 106 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 107 REPUBLIC OF KOREA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 108 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 110 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 111 REST OF ASIA-PACIFIC: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 112 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 113 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 114 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 115 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 116 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 117 MIDDLE EAST: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 118 MIDDLE EAST: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 119 MIDDLE EAST: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 120 MIDDLE EAST: ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 121 AFRICA: ANIMAL VACCINES MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 122 AFRICA: ANIMAL VACCINES MARKET, BY LIVESTOCK VACCINES, 2018–2027 (USD MILLION)

TABLE 123 AFRICA: ANIMAL VACCINES MARKET, BY COMPANION ANIMAL VACCINES, 2018–2027 (USD MILLION)

TABLE 124 AFRICA: ANIMAL VACCINES MARKET, BYTECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 125 MAJOR PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

TABLE 126 THE MOST ACTIVE PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

TABLE 127 NEW PRODUCT DEVELOPMENTS/LAUNCHES/PRODUCT LICENSING AGREEMENTS

TABLE 128 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

TABLE 129 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED

TABLE 130 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS

TABLE 131 ZOETIS INC.: PRODUCTS OFFERED

TABLE 132 ZOETIS INC.: KEY DEVELOPMENTS

TABLE 133 CEVA SANTÉ ANIMALE: PRODUCTS/SERVICES OFFERED

TABLE 134 CEVA SANTÉ ANIMALE: KEY DEVELOPMENTS

TABLE 135 MERCK & CO., INC.: PRODUCTS OFFERED

TABLE 136 MERCK & CO., INC.: KEY DEVELOPMENTS

TABLE 137 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED

TABLE 138 ELANCO ANIMAL HEALTH INCORPORATED: KEY DEVELOPMENTS

TABLE 139 VIRBAC: PRODUCTS OFFERED

TABLE 140 VIRBAC: KEY DEVELOPMENTS

TABLE 141 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED

TABLE 142 PHIBRO ANIMAL HEALTH CORPORATION: KEY DEVELOPMENTS

TABLE 143 HIPRA: PRODUCTS OFFERED

TABLE 144 HIPRA: KEY DEVELOPMENTS

TABLE 145 BIOGÉNESIS BAGÓ S.A.: PRODUCTS OFFERED

TABLE 146 BIOGÉNESIS BAGÓ S.A.: KEY DEVELOPMENTS

TABLE 147 NEOGEN CORPORATION: PRODUCTS OFFERED

TABLE 148 NEOGEN CORPORATION: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: ANIMAL VACCINES MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL ANIMAL VACCINES MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ANIMAL VACCINES MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBALANIMAL VACCINES MARKET

FIGURE 9 GLOBAL ANIMAL VACCINE MARKET, BY TYPE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: ANIMAL VACCINES MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 13 AMERICAS: ANIMAL VACCINES MARKET SHARE, BY REGION 2020 (%)

FIGURE 14 NORTH AMERICA: ANIMAL VACCINES MARKET SHARE, BY COUNTRY 2020 (%)

FIGURE 15 EUROPE: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 16 WESTERN EUROPE: ANIMAL VACCINES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 ASIA-PACIFIC: ANIMAL VACCINES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 18 MIDDLE EAST & AFRICA: ANIMAL VACCINES MARKET SHARE (%), BY REGION, 2020

FIGURE 19 EXPANSION: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ANIMAL VACCINES MARKET

FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 21 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 22 MAJOR PLAYERS R&D EXPENDITURE, 2020

FIGURE 23 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS

FIGURE 25 ZOETIS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ZOETIS INC.: SWOT ANALYSIS

FIGURE 27 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 MERCK & CO., INC.: SWOT ANALYSIS

FIGURE 29 ELANCO ANIMAL HEALTH INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ELANCO ANIMAL HEALTH INCORPORATED: SWOT ANALYSIS

FIGURE 31 VIRBAC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 VIRBAC: SWOT ANALYSIS

FIGURE 33 PHIBRO ANIMAL HEALTH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

ページTOPに戻る

Table of Contents

Summary

Animal Vaccines Market—Forecast to 2027

Market Forecast
Animal Vaccines Market is anticipated to witness a significant CAGR of 7.50% during the projected timeframe with the highest market value of USD 8,013.06 million in 2020. Animal vaccines market study incorporates market size examination and a thorough examination of the producer's items and administration methodologies. The development of the worldwide animal vaccines market is attributed to the rising zoonotic and ongoing infections in animals and expanding accentuation on animal medical services and inoculation. Be that as it may, high-capacity costs related to vaccines and rigid administrative rules are limiting variables for the animal vaccines market. Also, the development in the number of items sent off to vaccinate different species is inclining toward the development in the animal vaccines market.
As per the World Health Organization (WHO) insights, around 59,000 human passings happen every year by rabies infection across the globe. The spread of such sicknesses is adding to the rising interest in animal vaccines. Moreover, one of the primary purposes behind the developing number of ongoing illnesses is the rising future of pets because of the created medical care offices and great sustenance. Moreover, the animal health future relies upon innovative progression in animal wellbeing and unrivaled patient consideration, the advancement of new items, and the cooperative improvement of vaccines. Pet people are spending a higher sum to look for the best accessible medicines for their partners. This has prompted an expansion in interest in veterinary medical clinics. Moreover, legislatures across the globe are spending a huge sum on veterinary clinics.
Market Segmentation

The segmental analysis of the global Animal Vaccines market is carried out in terms of type, technology, and region.
In terms of type segment, the global market is categorized into Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, and Aquaculture vaccines. The technology segment divides the global market into Toxoid vaccines, Recombinant vaccines, live attenuated vaccines, Inactivated vaccines, and Others.

Regional Analysis

Geographically the global animal vaccines market is spread across four major regions namely the Americas, Europe, Asia-Pacific, and the Middle East, & Africa.
Americas is likely to lead the global animal vaccine market with the largest market share in 2020. The increasing incidences of animal diseases and the increasing pet adoption are expected to boost the regional market in the future. Also, the increasing cases of foot and mouth disease canine parvovirus, and reproductive and respiratory syndrome fuels the further market growth in the Americas.

The European region is anticipated to attain a notable market for animal vaccines followed by the Asia Pacific. The regional market is attributed to the increased population of pets and growing expenditure on research and development. The animal vaccines market in Asia-Pacific is attributed to the rising awareness of animal health, an increase in the livestock population, and the increasing number of cases of animal diseases.

Major Players
The key companies included in the global animal vaccines market research report are Ceva Santé Animale (France), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Biogénesis Bagó S.A.(Argentina), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), and Neogen Corporation (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Market Research Future 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

動物用ワクチン市場-2027年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Market Research Future 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?